Contact this trialFirst, we need to learn more about you.
Opioid Antagonist
Low Dose Naltrexone for Pain in HIV/AIDS
Recruiting3 awardsPhase 4
Atlanta, Georgia
This trial will test whether low-dose naltrexone, an opioid antagonist usually used in the treatment of alcohol and opioid use disorders, can relieve chronic pain in people living with HIV/AIDS. If successful, this inexpensive repurposing of the drug could expand access to treatment for a painful condition experienced by many people with HIV/AIDS.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service